精准医学研究最新文献

筛选
英文 中文
Investigating the effect of rubiadin cytotoxicity and expression of BAX and BCL2 genes on HepG2 liver cancer cell line 探讨红宝石定对HepG2肝癌细胞毒性及BAX、BCL2基因表达的影响
精准医学研究 Pub Date : 2023-01-01 DOI: 10.53388/pmr20230014
Sanaz Pashapour, Abbas Zabihi, Y. Hamidi, M. Heshmati
{"title":"Investigating the effect of rubiadin cytotoxicity and expression of BAX and BCL2 genes on HepG2 liver cancer cell line","authors":"Sanaz Pashapour, Abbas Zabihi, Y. Hamidi, M. Heshmati","doi":"10.53388/pmr20230014","DOIUrl":"https://doi.org/10.53388/pmr20230014","url":null,"abstract":"Background: Rubiadin is a type of anthraquinone compound that can be found in Rubiaceae plants, such as Ronas. Nonetheless, only limited research has been done to explore the potential anticancer properties of rubiadin on liver cancer cells. Thus, the objective of the present study is to examine how rubiadin affects the viability of liver cancer cells as well as normal cells. Methods: HepG2 and AGO cell lines were assigned into controls (not exposed to rubiadin) and groups with exposure to rubiadin with 12.5, 6.25, 3.125, 1.56, 0.78, and 0.39 μg/mL concentrations. 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide and reverse transcription-polymerase chain reaction were used to measure cell viability, and one-way analysis of variance was used for data analysis. Results: The viability of liver cancer cells was significantly reduced when exposed to 12.5, 6.25, 3.125, and 1.56 μg/mL concentrations ( P < 0.01). An IC 50 of 44.73 μg/mL was reported. Furthermore, the BAX gene’s relative expression ( P < 0.05) was significantly increased and the BCL2 gene expression ( P < 0.05) was significantly reduced. The average ratio of BAX gene expression to BCL2 increased significantly ( P < 0.01). Conclusion: This research showed that rubiadin decreases cell viability by increasing the ratio of BAX gene expression to BCL2. In addition rubiadin has no cytotoxic effect on normal cells.","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70817235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances on biological evaluation methods of programmed cell death protein-1/ligand-1 inhibitors 程序性细胞死亡蛋白-1/配体-1抑制剂生物学评价方法研究进展
精准医学研究 Pub Date : 2023-01-01 DOI: 10.53388/pmr20230011
Qi Miao, Wanwan Zhang
{"title":"Advances on biological evaluation methods of programmed cell death protein-1/ligand-1 inhibitors","authors":"Qi Miao, Wanwan Zhang","doi":"10.53388/pmr20230011","DOIUrl":"https://doi.org/10.53388/pmr20230011","url":null,"abstract":"Immuno-oncology represents a groundbreaking and well-established field within cancer treatment. Among the various immuno-oncology targets, the exploration of programmed cell death-1/ligand-1 for drug discovery has proven to be one of the most successful endeavors. Remarkably, it took nearly 30 years from the initial target identification to the clinical approval of monoclonal antibodies. Providing suitable and reliable bioassays for drug candidate evaluation is of paramount importance throughout the early stages of drug discovery, from lead compound identification to in vivo efficacy testing. This assay review aims to shed light on diverse assays reported in the literature for testing antagonism activity and efficacy of programmed cell death-1/ligand-1 inhibitors. Each of these assays possesses inherent advantages and can be applied in different research scenarios. The insights presented in this summary can serve as a valuable resource for scientists in this field, aiding in the selection of appropriate assays for their specific investigations.","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pan-cancer analysis of positive regulatory domain-containing 16 in human tumors 人肿瘤阳性调控域16的泛癌分析
精准医学研究 Pub Date : 2023-01-01 DOI: 10.53388/pmr20230012
Shining Zhang, Tingpeng Yang, Xiang He, Fang Yang, Lin Zhang
{"title":"Pan-cancer analysis of positive regulatory domain-containing 16 in human tumors","authors":"Shining Zhang, Tingpeng Yang, Xiang He, Fang Yang, Lin Zhang","doi":"10.53388/pmr20230012","DOIUrl":"https://doi.org/10.53388/pmr20230012","url":null,"abstract":"Background: Positive regulatory domain-containing 16 (PRDM16) plays a key role in brown adipose transcription, but its function in cancer is unclear. Our research to investigate the potential roles of PRDM16 across multiple types of cancer by pan cancer analyses. Methods: UALCAN and TIMER2 database were utilized to evaluate PRDM16 expression in cancer patients. Gene Expression Profiling Interactive Analysis was employed to analyze the overall survival and disease-free survival across all The Cancer Genome Atlas Program tumors. Using the cBioPortal tool, we analyzed the mutation features of PRDM16 for the The Cancer Genome Atlas Program tumors, then utilized the Encyclopedia of RNA Interactomes database to predict the miRNA-mRNA relationships associated with the PRDM16 for all tumors. Results: The expression level of PRDM16 in the tumor tissues is lower than that in the normal tissues. Interesting, the high expression of PRDM16 has a positive effect on the prognosis of kidney clear cell carcinoma and lung adenocarcinoma, but not conducive to the prognosis of most cancers. In multiple cancer types, the expression of PRDM16 was significantly positively correlated with immune infiltration of cancer-associated fibroblasts. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analysis indicated that PRDM16 may be related to transcriptional misregulation pathway in cancer. We identified potential miRNAs that play regulatory roles of PRDM16 in kidney clear cell carcinoma and lung adenocarcinoma. Conclusion: PRDM16 is expressed in different cancers, it can be used as a biomarker for prognosis of pan-cancer and is associated with immune infiltration.","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"21 3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of estrogen-mediated ubiquitin on cardiovascular diseases: a bioinformatics analysis 雌激素介导的泛素对心血管疾病的影响:生物信息学分析
精准医学研究 Pub Date : 2023-01-01 DOI: 10.53388/pmr20230002
Nan Li, Yu-Han Duan, Kun Zhang
{"title":"The effect of estrogen-mediated ubiquitin on cardiovascular diseases: a bioinformatics analysis","authors":"Nan Li, Yu-Han Duan, Kun Zhang","doi":"10.53388/pmr20230002","DOIUrl":"https://doi.org/10.53388/pmr20230002","url":null,"abstract":"","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suppressed effects of Phyllanthus urinaria L. ethyl acetate extract on hepatitis B virus both in vitro and in vivo 茶树叶乙酸乙酯提取物对乙型肝炎病毒体外和体内的抑制作用
精准医学研究 Pub Date : 2023-01-01 DOI: 10.53388/pmr20230015
Zhilong Chen, Rui Zhang
{"title":"Suppressed effects of Phyllanthus urinaria L. ethyl acetate extract on hepatitis B virus both in vitro and in vivo","authors":"Zhilong Chen, Rui Zhang","doi":"10.53388/pmr20230015","DOIUrl":"https://doi.org/10.53388/pmr20230015","url":null,"abstract":"Background: Phyllanthus urinaria L. ( P. urinaria ) extract (PUE) has been used to inhibit hepatitis B virus (HBV). However, the underlying mechanism remains unclear. To investigate which PUE fractions and main components lead to against HBV and approach the relevant molecular mechanisms. Methods: P. urinaria was extracted with water, and then the decoction was extracted by petroleum ether, ethyl acetate, and n-butanol in turn. The HepG2.2.15 cell was treated with aqueous fraction, petroleum ether fraction, ethyl acetate fraction and n-butanol fraction, gallic acid (GA, C 7 H 6 O 5 ) and corilagin (CL, C 27 H 22 O 18 ), respectively. The medium was collected for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen assays. Cell counting kit-8 method was used to identify cell proliferation. Also, the levels of cellular oxygen consumption, reactive oxygen species, and reduced glutathione were detected. The HBV modeling mice were treated with ethyl acetate fraction, entecavir and physiological saline, respectively. The serum was collected for HBsAg and inflammatory cytokines assays. Liver tissue metabolites were screened by LC-MS/MS method. Results: The ethyl acetate fraction (EAF) of P. urinaria could significantly inhibit HBV secretion in HepG2.2.15 ( P < 0.05). Furthermore, two main constitutes in ethyl acetate fraction, GA and CL, could significantly inhibit HBV secretion and reduced cell proliferation ( P < 0.05). Also, GA and CL could increase cellular oxygen consumption, intracellular superoxide anions level, superoxide dismutase level and glutathione depletion. Compared with the Modeling group, EAF significantly decreased the expression levels of HBsAg, IL-1β, IFN-α ( P < 0.05). LC-MS/MS analysis results showed that EAF dramatically up-regulate hydroxyproline, maltotriose, betaine and down-regulate glutathione disulfide, taurocholate, taurochenodeoxycholate ( P < 0.05). Kyoto Encyclopedia of Genes and Genomes results show that the differential metabolites were mainly enriched in ATP-binding cassette transporters pathway. Conclusions: P. urinaria exhibits suppressed effects on HBV by modulating reactive oxygen species formation or metabolomics both in vitro and in vivo. These data indicate that P. urinaria may be an alternative therapeutic agent for the treatment of HBV-related hepatitis.","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70817287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recognition of prognostic biomarker and its association with immune infiltrates in breast cancer associated with inflammation 乳腺癌炎症相关的预后生物标志物识别及其与免疫浸润的关系
精准医学研究 Pub Date : 2022-01-01 DOI: 10.53388/pmr20220001
Shunjin Wang, Zhi Li, Huan Zhang, Qun Wang
{"title":"Recognition of prognostic biomarker and its association with immune infiltrates in breast cancer associated with inflammation","authors":"Shunjin Wang, Zhi Li, Huan Zhang, Qun Wang","doi":"10.53388/pmr20220001","DOIUrl":"https://doi.org/10.53388/pmr20220001","url":null,"abstract":"","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70815969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic implication and oncogenic role of RHCG in lung adenocarcinoma RHCG在肺腺癌中的预后意义及致瘤作用
精准医学研究 Pub Date : 2022-01-01 DOI: 10.53388/pmr20220013
Yidan Sun, Xiaojiang Li, Peiying Yang, Minna Huang, Yingjie Jia
{"title":"Prognostic implication and oncogenic role of RHCG in lung adenocarcinoma","authors":"Yidan Sun, Xiaojiang Li, Peiying Yang, Minna Huang, Yingjie Jia","doi":"10.53388/pmr20220013","DOIUrl":"https://doi.org/10.53388/pmr20220013","url":null,"abstract":"","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of bisphenol A action on genes interfering with estrogen signaling pathways and the development of endometriosis 双酚A对雌激素信号通路干扰基因的作用与子宫内膜异位症发生的相关性
精准医学研究 Pub Date : 2022-01-01 DOI: 10.53388/pmr20220012
Nan Li, Yuhan Duan, Lei Chen, Kun Zhang
{"title":"Correlation of bisphenol A action on genes interfering with estrogen signaling pathways and the development of endometriosis","authors":"Nan Li, Yuhan Duan, Lei Chen, Kun Zhang","doi":"10.53388/pmr20220012","DOIUrl":"https://doi.org/10.53388/pmr20220012","url":null,"abstract":"","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Mig6 gene in tumor research Mig6基因在肿瘤研究中的进展
精准医学研究 Pub Date : 2022-01-01 DOI: 10.53388/pmr20220005
YeMinXiao Zeng, An Yan, Zhonggang Wu, Wenjie Zeng, Huaiyuan Zheng, Xiuling Wei, Shibo Zhao, Zihui Liu
{"title":"Advances in Mig6 gene in tumor research","authors":"YeMinXiao Zeng, An Yan, Zhonggang Wu, Wenjie Zeng, Huaiyuan Zheng, Xiuling Wei, Shibo Zhao, Zihui Liu","doi":"10.53388/pmr20220005","DOIUrl":"https://doi.org/10.53388/pmr20220005","url":null,"abstract":"","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical research progress of first-line immunotherapy for extensive-stage small cell lung cancer 广泛期小细胞肺癌一线免疫治疗的临床研究进展
精准医学研究 Pub Date : 2022-01-01 DOI: 10.53388/pmr20220004
Yongchao Yu, Hongxia Xie, Jinhui Zuo, Xiaojiang Li, Yingjie Jia, F. Kong
{"title":"Clinical research progress of first-line immunotherapy for extensive-stage small cell lung cancer","authors":"Yongchao Yu, Hongxia Xie, Jinhui Zuo, Xiaojiang Li, Yingjie Jia, F. Kong","doi":"10.53388/pmr20220004","DOIUrl":"https://doi.org/10.53388/pmr20220004","url":null,"abstract":"","PeriodicalId":59651,"journal":{"name":"精准医学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信